Management of Dyslipidemia and Hyperglycemia With a Fixed-Dose Combination of Sitagliptin and Simvastatin

Vascular Health and Risk Management
doi 10.2147/vhrm.s44330
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Simvastatin Plus Fenofibrate as a Fixed Dose Combination in the Treatment of Mixed Dyslipidemia in Greece: Budget Impact Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Enantiometric Separation of Sitagliptin in a Fixed Dose Combination Formula of Sitagliptin and Metformin by a Chiral Liquid Chromatographic Method

International Journal of Pharmacy and Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2019English

Bioequivalence of Ertugliflozin/Sitagliptin Fixed-Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components

Clinical Pharmacology in Drug Development
PharmacologyPharmaceutical Science
2019English

Simvastatin/Fenofibrate Combination in the Treatment of Dyslipidemia: Current Evidence

Research and Reports in Endocrine Disorders
2014English

A Retrospective Comparison Study Between the Effectiveness and Safety of Fixed Dose Combination of Vildagliptin Versus Sitagliptin With Metformin in Type 2 Diabetes Mellitus Patients

Indian Journal of Pharmacy Practice
2018English

Management of Hyperglycemia, Dyslipidemia, and Albuminuria in Patients With Diabetes and CKD: A Systematic Review for a KDOQI Clinical Practice Guideline

American Journal of Kidney Diseases
Nephrology
2012English

Synergistically Active and Safe Fixed Dose Combination of Meropenem and Sulbactam

IIOAB Letters
2013English

Drowsiness Associated With a Generic Fixed‐dose Glibenclamide/Metformin Combination Tablet

Journal of Pharmacy Practice and Research
PharmacologyPharmacy
2019English

The Pharmacokinetic Profile of a Novel Fixed-Dose Combination Tablet of Ibuprofen and Paracetamol

BMC Clinical Pharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy